$BCAX
Bicara Therapeutics Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateBicara Therapeutics Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is BCAX down today? It is at $16.78 (-4.77%), and our scanner flagged it 86 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment BCAX spikes, and full due diligence on BCAX — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $BCAX 86 times in the last 30 days. Create a free account to track $BCAX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on BCAX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for BCAX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Cohlhepp Ryan Officer | Sold (automatic/other) | -18K 0.03% of company | sold 8.8% | 182K | $398K at $22.77 | Sep 8, 26 |
Cohlhepp Ryan Officer | Other | 18K 0.03% of company | added 9.6% | 199K | $66K at $3.79 | Sep 8, 26 |
Cohlhepp Ryan Officer | Sold (automatic/other) | -19K 0.03% of company | sold 9.4% | 182K | $525K at $27.98 | Aug 10, 26 |
Cohlhepp Ryan Officer | Other | 19K 0.03% of company | added 10% | 200K | $71K at $3.79 | Aug 10, 26 |
Mazumdar Claire Officer | Sold (automatic/other) | -10K 0.02% of company | sold 2.7% | 362K | $280K at $27.98 | Aug 10, 26 |
Mazumdar Claire Officer | Other | 10K 0.02% of company | added 2.8% | 372K | $38K at $3.79 | Aug 10, 26 |
Hyep Ivan Officer | Sold (automatic/other) | -13K 0.02% of company | sold 8.8% | 130K | $350K at $27.97 | Aug 10, 26 |
Hyep Ivan Officer | Other | 13K 0.02% of company | added 9.6% | 142K | $47K at $3.79 | Aug 10, 26 |
Mazumdar Claire Officer | Sold (automatic/other) | -10K 0.02% of company | sold 2.7% | 362K | $284K at $28.42 | Jul 10, 26 |
Mazumdar Claire Officer | Other | 10K 0.02% of company | added 2.8% | 372K | $38K at $3.79 | Jul 10, 26 |
Cohlhepp Ryan Officer | Sold (automatic/other) | -536 | sold 0.3% | 182K | $16K at $29.00 | Jul 9, 26 |
Hyep Ivan Officer | Sold (automatic/other) | -28K 0.04% of company | sold 18% | 130K | $801K at $28.60 | Jul 8, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on BCAX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for BCAX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
BCAX last traded at $16.78, down 4.77% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Bicara Therapeutics Inc. Common Stock (BCAX) is next expected to report earnings on Monday, November 9, 2026, about 22 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The BCAX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged BCAX 86 times in the last 30 days.
BCAX (Bicara Therapeutics Inc. Common Stock) trades on XNAS, with a market cap of about $1.11B in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge BCAX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$BCAX discussion
Sign in to ask a question or join the discussion.